René Scholtysik

924 citations
25 papers · 448 indexed · h-index 13
Topics
Lymphoma Diagnosis and Treatment (11 papers)Chronic Lymphocytic Leukemia Research (10 papers)Gut microbiota and health (4 papers)

In The Last Decade

René Scholtysik

25 papers receiving 445 citations

Peers

René Scholtysik
Comparison fields: 5 of 64
  • Pathology and Forensic Medicine 193
  • Molecular Biology 153
  • Oncology 136
  • Immunology 116
  • Genetics 113
Replace MF Fey with:
MF Fey Switzerland
Debasmita Roy United States
Anke K. Bergmann Germany
Werner Olipitz United States
Carmen Hernández‐López Spain
Maija Lepistö Finland
Paola Temperani Italy
Matthew Schrage United States
Sarah Pogue United States
Katarina Dahlenborg Sweden
René Scholtysik relative to MF Fey Switzerland MF Fey's profile →
Citations per field
00.5×4.3×
MF Fey · 1×
Citations per year

Countries citing papers authored by René Scholtysik

Since Specialization
Citations

This map shows the geographic impact of René Scholtysik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by René Scholtysik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites René Scholtysik more than expected).

Fields of papers citing papers by René Scholtysik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by René Scholtysik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by René Scholtysik. The network helps show where René Scholtysik may publish in the future.

Co-authorship network of co-authors of René Scholtysik

This figure shows the co-authorship network connecting the top 25 collaborators of René Scholtysik. A scholar is included among the top collaborators of René Scholtysik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with René Scholtysik. René Scholtysik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 11
4 2
5 13
6 5
7 3
8 20
9 44
10 1
11 6
12 27
13 4
14 28
15 41
16 51
17 8
18 25
19 12
20 24

About René Scholtysik

René Scholtysik is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology, having authored 25 papers that have together received 448 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Gut microbiota and health (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (193 citations), Genetics (113 citations) and Immunology (116 citations). René Scholtysik has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Ralf Küppers, Marc Seifert, Ludger Klein‐Hitpaß, Ulrich Dührsen, Jan Dürig, Reiner Siebert, Markus Kreuz, Andreas Hüttmann, Patricia Johansson and Martin‐Leo Hansmann. Their work appears in journals such as PLoS ONE, International Journal of Cancer and The Journal of Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026